Dermatomyositis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Kiran Singh (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Dermatomyositis}} | {{Dermatomyositis}} | ||
{{CMG}} | |||
==Overview== | |||
==Epidemiology and Demographics== | |||
===Incidence=== | |||
===Prevalence=== | |||
===Case Fatality Rate=== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
===Developing Countries=== | |||
===Developed Countries=== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 13:48, 14 June 2016
|
Dermatomyositis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatomyositis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Dermatomyositis epidemiology and demographics |
|
Risk calculators and risk factors for Dermatomyositis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]